CompletedPhase 4

ARTISS a Single-centre Randomised Control Study

United Kingdom135 participantsStarted 2022-02-01

Plain-language summary

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female adult (age 18-80) * Patients planned for immediate or delayed DIEP/MS-TRAM breast reconstruction Exclusion Criteria: * Patients who are unable to consent or do not consent * Clotting disorder * Pregnancy * Individuals whose immune system is depressed or who have some types of anaemia (e.g. sickle cell disease or haemolytic anaemia). * COVID positive * Known previous allergic reactions to ARTISS

What they're measuring

post-operative abdominal mean drainage duration

Timeframe: 42 days

Trial details

NCT IDNCT04931615

SponsorMid and South Essex NHS Foundation Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-28

View on ClinicalTrials.gov More Breast Neoplasms trials